Tuesday, February 27, 2018 3:12:49 PM
Questions as Tullow gives up lucrative oil block
By Macharia Kamau | Published Tue, February 27th 2018 at 00:00
Tullow Oil plans to relinquish its status as the operator of what could be the most lucrative exploration blocks outside the Lokichar Basin to a little known UK firm. This means that Tullow Oil, whose activities in Lokichar have been by far the most successful in the country’s exploration history, will stop playing the critical role of the day-to-day running of block 12A in Kerio Valley. The role of undertaking seismic surveys, exploratory drilling and other activities that lead up to oil discoveries will now be handled by Delonex Energy, also headquartered in the UK.
Read more at:
https://www.standardmedia.co.ke/business/article/2001271269/questions-as-tullow-gives-up-lucrative-oil-block
Read about Delonex Energy
http://www.delonexenergy.com/about-us/
http://www.delonexenergy.com/about-us/seniormanagement/
http://www.delonexenergy.com/about-us/strategy-and-approach/
The Delonex vision is to unlock the hydrocarbon potential of Sub-Saharan Africa and create value for host governments.
We access exploration opportunities through licence rounds, farm-ins and direct awards from host governments. In addition we are actively evaluating acquisition of discovered resources and producing assets.
Delonex is well placed to access opportunities in the current market environment by leveraging:
Committed capital from our investors
Our expertise in fast track exploration, development and monetisation of resources
Our experience in maximising returns on assets through operating efficiency enhancements
Our ability to mobilise expertise and people fast, to deliver best-in-class technology and execution
Backed by leading energy investors with in-depth African expertise and proven track record in the E&P sector
Financed by $600m of equity capital from the International Finance Corporation (IFC) and Warburg Pincus, supplemented by access to debt including project finance.
No Presentation to view
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM